☰

Hatice U. Osmanbeyoglu - Publications

Affiliations: 
Biomedical Informatics University of Pittsburgh School of Medicine, Pittsburgh, PA, United States 
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lee S, Cho Y, Li Y, Li R, Brown D, McAuliffe P, Lee AV, Oesterreich S, Zervantonakis IK, Osmanbeyoglu HU. Cancer-cell derived S100A11 promotes macrophage recruitment in ER+ breast cancer. Biorxiv : the Preprint Server For Biology. PMID 38585952 DOI: 10.1101/2024.03.21.586041  0.308
2022 Tao Y, Ma X, Palmer D, Schwartz R, Lu X, Osmanbeyoglu HU. Interpretable deep learning for chromatin-informed inference of transcriptional programs driven by somatic alterations across cancers. Nucleic Acids Research. PMID 36243974 DOI: 10.1093/nar/gkac881  0.361
2019 Osmanbeyoglu HU, Shimizu F, Rynne-Vidal A, Alonso-Curbelo D, Chen HA, Wen HY, Yeung TL, Jelinic P, Razavi P, Lowe SW, Mok SC, Chiosis G, Levine DA, Leslie CS. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers. Nature Communications. 10: 4369. PMID 31554806 DOI: 10.1038/S41467-019-12291-6  0.442
2019 Osmanbeyoglu HU, Shimizu F, Rynne-Vidal A, Yeung T, Jelinic P, Mok SC, Chiosis G, Levine DA, Leslie C. Abstract 3370: Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3370  0.369
2018 Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman DI, Tarpey P, Danilova L, Drill E, Gibb EA, Bowlby R, Kanchi R, Osmanbeyoglu HU, Sekido Y, Takeshita J, et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discovery. PMID 30322867 DOI: 10.1158/2159-8290.Cd-18-0804  0.388
2018 Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, ... ... Osmanbeyoglu HU, et al. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily. Cell Systems. PMID 30268436 DOI: 10.1016/J.Cels.2018.08.010  0.366
2018 Korkut A, Zaidi S, Kanchi R, Berger AC, Robertson G, Kwong LN, Datto M, Roszik J, Ling S, Schultz A, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, ... ... Osmanbeyoglu H, et al. Abstract 3413: A pan-cancer atlas of genomic, epigenomic and transcriptomic alterations in the TGF-β pathway Cancer Research. 78: 3413-3413. DOI: 10.1158/1538-7445.Am2018-3413  0.417
2018 Osmanbeyoglu HU, Jelinic P, Levine D, Leslie CS. Abstract LB-A04: Transcriptional regulatory programs in gynecological cancers Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-Lb-A04  0.472
2017 Nargund AM, Osmanbeyoglu HU, Cheng EH, Hsieh JJ. SWI/SNF tumor suppressor gene PBRM1/BAF180 in human clear cell kidney cancer. Molecular & Cellular Oncology. 4: e1342747. PMID 28868352 DOI: 10.1080/23723556.2017.1342747  0.426
2017 Toska E, Osmanbeyoglu HU, Castel P, Chan C, Hendrickson RC, Elkabets M, Dickler MN, Scaltriti M, Leslie CS, Armstrong SA, Baselga J. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. Science (New York, N.Y.). 355: 1324-1330. PMID 28336670 DOI: 10.1126/Science.Aah6893  0.405
2017 Osmanbeyoglu HU, Toska E, Chan C, Baselga J, Leslie CS. Pancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs. Nature Communications. 8: 14249. PMID 28139702 DOI: 10.1038/Ncomms14249  0.463
2017 Osmanbeyoglu HU, Leslie C. Abstract LB-010: Modeling the impact of mutations in ubiquitin pathway genes across human cancers Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-010  0.38
2017 Iyer AS, Osmanbeyoglu HU, Leslie CS. Computational methods to dissect gene regulatory networks in cancer Current Opinion in Systems Biology. 2: 115-122. DOI: 10.1016/J.Coisb.2017.04.004  0.419
2016 Toska E, Osmanbeyoglu H, Elkabets M, Chan C, Castel P, Dickler M, Armstrong S, Leslie C, Scaltriti M, José B. Abstract 885: Epigenetic regulation of estrogen receptor transcription by the PI3K pathway in breast cancer Cancer Research. 76: 885-885. DOI: 10.1158/1538-7445.Am2016-885  0.457
2016 Osmanbeyoglu HU, Toska E, Baselga J, Leslie C. Abstract 781: Modeling the impact of somatic alterations across human cancers Cancer Research. 76: 781-781. DOI: 10.1158/1538-7445.Am2016-781  0.48
2015 Osmanbeyoglu HU, Leslie C. Abstract LB-C04: Modeling the impact of somatic alterations across human cancers Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Lb-C04  0.482
2014 Osmanbeyoglu HU, Pelossof R, Bromberg JF, Leslie CS. Linking signaling pathways to transcriptional programs in breast cancer. Genome Research. 24: 1869-80. PMID 25183703 DOI: 10.1101/Gr.173039.114  0.465
2013 Osmanbeyoglu HU, Lu KN, Oesterreich S, Day RS, Benos PV, Coronnello C, Lu X. Estrogen represses gene expression through reconfiguring chromatin structures. Nucleic Acids Research. 41: 8061-71. PMID 23821662 DOI: 10.1093/Nar/Gkt586  0.355
2012 Osmanbeyoglu HU, Hartmaier RJ, Oesterreich S, Lu X. Improving ChIP-seq peak-calling for functional co-regulator binding by integrating multiple sources of biological information. Bmc Genomics. 13: S1. PMID 22369349 DOI: 10.1186/1471-2164-13-S1-S1  0.326
Show low-probability matches.